Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Repurposing Metformin for Covid-19 Complications in Patients With Type 2 Diabetes and Insulin Resistance Publisher Pubmed



Hashemi P1 ; Pezeshki S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Medicine, Tehran University of Medical Science (TUMS), Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, Iran University of Medical Science (IUMS), Tehran, Iran

Source: Immunopharmacology and Immunotoxicology Published:2021


Abstract

Understanding the exact role of current drugs in Covid-19 disease is essential in the era of global pandemics. Metformin which prescribed as the first-line treatment of type 2 diabetes has beneficial effects on Sars-cov2 infection. These effects are including regulation of immune system, Renin-Angiotensin System and Dipeptidyl Peptidase 4 function in Covid-19 infection. It also activates ACE2, the main receptor of Sars-cov2, in the epithelial cells of respiratory tissue through AMPK signaling and subsequently decreases the rate of viral adhesion. Metformin also declines the adherence of Sars-cov2 to DPP4 (the other receptor of the virus) on T cells. Hence, regulatory effects of metformin on membranous ACE2, and DPP4 can modulate immune reaction against Sars-cov2. Also, immunometabolic effects of metformin on inflammatory cells impair hyper-reactive immune response against the virus through reduction of glycolysis and propagation of mitochondrial oxidation. Metformin also decreases platelet aggravation and risk of thrombosis. In this article, we argue that metformin has beneficial effects on Covid-19 infection in patients with type 2 diabetes and insulin resistance. This opinion should be investigated in future clinical trials. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
2. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
3. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
4. Immunoediting in Sars-Cov-2: Mutual Relationship Between the Virus and the Host, International Immunopharmacology (2022)
5. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
6. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
7. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?, ACS Pharmacology and Translational Science (2021)
8. Genetic Susceptibility of Covid-19: A Systematic Review of Current Evidence, European Journal of Medical Research (2021)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (4)
Nima Rezaei (3)
Other Related Docs
9. Predictors of Mortality in Patients With Covid-19–A Systematic Review, European Journal of Integrative Medicine (2020)
10. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
11. The Potential Impact of Covid-19 on Cns and Psychiatric Sequels, Asian Journal of Psychiatry (2022)
12. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
13. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
14. Covid-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions, Frontiers in Cell and Developmental Biology (2021)
15. Risk Factors Affecting the Mortality of Covid-19 Patients: Impacts of Modifiable Factors, Iranian Journal of Health and Environment (2021)
16. Putative Therapeutic Impact of Inflammasome Inhibitors Against Covid-19-Induced Ards, Current Medicinal Chemistry (2023)
17. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
18. Covid-19 Pandemic and Periodontal Practice: The Immunological, Clinical, and Economic Points of View, BioMed Research International (2022)
19. Black Fungus and Beyond: Covid-19 Associated Infections, Clinical Imaging (2022)
20. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
21. Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review, Journal of Diabetes and Metabolic Disorders (2021)
22. The Role of Lovastatin in the Attenuation of Covid-19, International Immunopharmacology (2021)
23. Covid-19 in Patients With Diabetes: Factors Associated With Worse Outcomes, Journal of Diabetes and Metabolic Disorders (2021)
24. Effects of Angiotensin Receptor Blockers (Arbs) on Clinical Outcomes of Patients With Hypertension and Covid-19: A 7-Month Follow-Up Cohort Study, Journal of Cardiovascular and Thoracic Research (2022)
25. The Association of Ct-Measured Cardiac Indices With Lung Involvement and Clinical Outcome in Patients With Covid-19, Academic Radiology (2021)
26. Clinical Manifestation of Patients Who Died Due to Covid-19; a Retrospective Study From Qom-Iran, Archives of Iranian Medicine (2020)
27. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)
28. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)
29. The Therapeutic Activities of Metformin: Focus on the Nrf2 Signaling Pathway and Oxidative Stress Amelioration, Current Molecular Pharmacology (2023)
30. Complement Inhibition: A Possible Therapeutic Approach in the Fight Against Covid-19, Reviews in Medical Virology (2022)
31. Molecular Mechanisms and Therapeutic Effects of Different Vitamins and Minerals in Covid-19 Patients, Journal of Trace Elements in Medicine and Biology (2022)
32. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
33. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
34. The Effects of Annual Sz Drug on Dynamic Changes in Lymphocytes and Cytokines of Covid-19 Patients: A Randomized Clinical Trial, International Immunopharmacology (2024)
35. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
36. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
37. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
38. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
39. Obesity in Covid-19 Era, Implications for Mechanisms, Comorbidities, and Prognosis: A Review and Meta-Analysis, International Journal of Obesity (2021)
40. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
41. The Prognostic Significance of Insulin Resistance in Covid-19: A Review, Journal of Diabetes and Metabolic Disorders (2024)
42. An Insight Into the Sex Differences in Covid-19 Patients: What Are the Possible Causes?, Prehospital and Disaster Medicine (2020)
43. Pathophysiological Clues to How the Emergent Sars-Cov-2 Can Potentially Increase the Susceptibility to Neurodegeneration, Molecular Neurobiology (2021)
44. Clinical and Radiologic Characteristics of Covid-19 in Patients With Ckd, Iranian Journal of Kidney Diseases (2020)
45. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
46. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)